(MOM30IETF) Icicipramc Icicimom30 MACD charts technical analysis
(MOM30IETF) Icicipramc Icicimom30 MACD charts technical analysis MACD analysis of Icicipramc Icicimom30 | Buy/Sell Icicipramc Icicimom30
10 day averaged volume of Icicipramc Icicimom30 is 1109341
Date | Closing Price | Open | High | Low | Volume |
07 Mon Jul 2025 | 31.97 | 32.16 | 32.16 | 31.90 | 0.688 Mn |
04 Fri Jul 2025 | 32.02 | 32.19 | 32.19 | 31.88 | 0.671 Mn |
03 Thu Jul 2025 | 32.10 | 31.50 | 32.42 | 31.50 | 1.088 Mn |
02 Wed Jul 2025 | 32.31 | 32.43 | 32.64 | 32.17 | 0.933 Mn |
01 Tue Jul 2025 | 32.50 | 32.60 | 32.60 | 32.39 | 1.82 Mn |
30 Mon Jun 2025 | 32.49 | 32.55 | 33.18 | 32.26 | 1.112 Mn |
27 Fri Jun 2025 | 32.44 | 31.61 | 32.69 | 31.61 | 1.615 Mn |
26 Thu Jun 2025 | 32.43 | 31.90 | 33.61 | 31.90 | 0.828 Mn |
25 Wed Jun 2025 | 32.27 | 32.09 | 32.37 | 32.09 | 0.773 Mn |
24 Tue Jun 2025 | 32.08 | 32.29 | 32.43 | 32.05 | 1.37 Mn |
Indicators analysis of Icicipramc Icicimom30 (MOM30IETF)
MACD generated a SELL signal for Icicipramc Icicimom30 in short term but the sell signal is initial and weak.
MACD charts
Price action analysis of Icicipramc Icicimom30 ( (MOM30IETF) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Icicipramc Icicimom30 ( (MOM30IETF) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Icicipramc Icicimom30 ( (MOM30IETF) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Icicipramc Icicimom30 ( (MOM30IETF) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Icicipramc Icicimom30 stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Icicipramc Icicimom30 in short term but the sell signal is initial and weak.
Icicipramc Icicimom30 Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Icicipramc Icicimom30 in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Icicipramc Icicimom30 is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 32.3 and Icicipramc Icicimom30 (MOM30IETF) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Icicipramc Icicimom30 (MOM30IETF) stock. Volume based technical analysis of Icicipramc Icicimom30 (MOM30IETF) stock is negative.
Icicipramc Icicimom30 Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Click here for Icicipramc Icicimom30 charts
Click here for further forecast and predictions for tomorrow
COMMODITY Gainers BSE Gainers BSE Losers BSE Scanner CLOSED NEAR HIGH BSE Scanner CLOSED NEAR LOW USA Gainers USA Losers USA Scanner CLOSED NEAR HIGH USA Scanner CLOSED NEAR LOW USA Scanner UPTRENDING USA Scanner DOWNTRENDING
Munafa NEWSTerms of Use Stock Market News! © munafa.org.in2025 All Rights reserved.